Ascendis Pharma Correlations

Ascendis Pharma Market Correlation

Ascendis Pharma has a market cap of 14.13 billion, an operating margin of 0.96% (TTM), current ratio of 9.66. Liquidity ratios should be evaluated alongside debt maturity schedules for a complete picture. Sector and industry overlap across positions affects concentration risk. Broader economic conditions can influence Ascendis Pharma AS's company valuation - related indicators include signals in persons.

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations GH + 0.81 IONS SMMT + 0.73 RVMD MDGL + 0.72 SMMT BMRN + 0.68 IONS MRNA + 0.68 ROIV BMRN + 0.66 GH

High negative correlations BMRN - 0.68 MDGL BMRN - 0.6 SMMT MRNA - 0.56 GH BMRN - 0.52 RVMD MRNA - 0.49 IONS GH - 0.39 SMMT

Risk-Adjusted Indicators

Strong recent returns in Ascendis Pharma Stock do not always mean Ascendis Pharma Company is outperforming peers on business quality. Reviewing Ascendis Pharma's risk-adjusted indicators gives a clearer view of whether returns are being earned efficiently. These indicators are quantitative in nature and measure volatility and risk-adjusted expected returns across different positions.